Antibiotic resistance represents the greatest threat in the field of infectious diseases today, due to the sharp increase of this event both in Europe and the World. The presence of these multidrug-resistant microorganisms in hospitals is associated with many risks, including the increased likelihood of treatment failure, an increased risk of morbidity and mortality, longer hospital stay, higher hospitalization costs and more legal disputes. The epidemiology of multidrug-resistant microorganisms infections varies from year to year, by geographical area, by hospital and by ward or department. Italy lies in fifth place among European countries regarding the use of antibiotics in human and veterinary clinical practice. Unfortunately, antibiotic resistance remains one of the highest in Europe and is consistently above the European average for both Gram negative and positive bacteria. The appearance and the growth of resistance to Carbapenems has been rapid, alarming and dramatic in Italy so much that the country is now classified as hyperendemic. It is important to highlight the known and emerging risk factors to define multidrug-resistant microorganisms prevention and control measures, both at individual and community level.

Antibiotic resistance: where are we going?

ALESSI, Valeria
Membro del Collaboration Group
;
LA FAUCI, Vincenza
2018-01-01

Abstract

Antibiotic resistance represents the greatest threat in the field of infectious diseases today, due to the sharp increase of this event both in Europe and the World. The presence of these multidrug-resistant microorganisms in hospitals is associated with many risks, including the increased likelihood of treatment failure, an increased risk of morbidity and mortality, longer hospital stay, higher hospitalization costs and more legal disputes. The epidemiology of multidrug-resistant microorganisms infections varies from year to year, by geographical area, by hospital and by ward or department. Italy lies in fifth place among European countries regarding the use of antibiotics in human and veterinary clinical practice. Unfortunately, antibiotic resistance remains one of the highest in Europe and is consistently above the European average for both Gram negative and positive bacteria. The appearance and the growth of resistance to Carbapenems has been rapid, alarming and dramatic in Italy so much that the country is now classified as hyperendemic. It is important to highlight the known and emerging risk factors to define multidrug-resistant microorganisms prevention and control measures, both at individual and community level.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/3128053
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 9
social impact